44 related articles for article (PubMed ID: 2757911)
1. Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols.
Kroczka S; Stepien K; Witek-Motyl I; Kwiecinska K; Kapusta E; Biedron A; Skorek P; Skoczen S
BMC Cancer; 2021 Feb; 21(1):150. PubMed ID: 33568096
[TBL] [Abstract][Full Text] [Related]
2. Full-field ERG and visual fields in patients 5 years after discontinuing vigabatrin therapy.
Kjellström U; Lövestam-Adrian M; Andréasson S; Ponjavic V
Doc Ophthalmol; 2008 Sep; 117(2):93-101. PubMed ID: 18188629
[TBL] [Abstract][Full Text] [Related]
3. Examining visual field defects in the paediatric population exposed to vigabatrin.
Spencer EL; Harding GF
Doc Ophthalmol; 2003 Nov; 107(3):281-7. PubMed ID: 14711160
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin; its effect on the electrophysiology of vision.
Harding GF; Robertson K; Spencer EL; Holliday I
Doc Ophthalmol; 2002 Mar; 104(2):213-29. PubMed ID: 11999628
[TBL] [Abstract][Full Text] [Related]
5. Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication.
Ponjavic V; Andréasson S
Doc Ophthalmol; 2001 Jan; 102(1):63-72. PubMed ID: 11475366
[TBL] [Abstract][Full Text] [Related]
6. A risk-benefit assessment of vigabatrin in the treatment of neurological disorders.
Srinivasan J; Richens A
Drug Saf; 1994 May; 10(5):395-405. PubMed ID: 8037889
[TBL] [Abstract][Full Text] [Related]
7. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.
Yuksel A; Senocak D; Sozuer D; Keskin G; Dirican A; Cenani A; Yalcin E
Childs Nerv Syst; 1995 Aug; 11(8):474-7. PubMed ID: 7585685
[TBL] [Abstract][Full Text] [Related]
8. Place of newer antiepileptic drugs in the treatment of epilepsy.
Kälviäinen R; Keränen T; Riekkinen PJ
Drugs; 1993 Dec; 46(6):1009-24. PubMed ID: 7510609
[TBL] [Abstract][Full Text] [Related]
9. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
[TBL] [Abstract][Full Text] [Related]
10. Effect of vigabatrin (gamma-vinyl-GABA) on visual, brainstem auditory and somatosensory evoked potentials in epileptic patients.
Cosi V; Callieco R; Galimberti CA; Manni R; Tartara A; Lanzi G; Balottin U; Perucca E
Eur Neurol; 1988; 28(1):42-6. PubMed ID: 3130253
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
Grant SM; Heel RC
Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266
[TBL] [Abstract][Full Text] [Related]
12. [Recent findings on generators of evoked potentials].
Meccia A; Mollica MA; Quadrini R; Morocutti C
Riv Neurol; 1989; 59(4):127-41. PubMed ID: 2694312
[TBL] [Abstract][Full Text] [Related]
13. Effects of vigabatrin on evoked potentials in epileptic patients.
Cosi V; Callieco R; Galimberti CA; Manni R; Tartara A; Mumford J; Perucca E
Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):61S-68S. PubMed ID: 2757911
[TBL] [Abstract][Full Text] [Related]
14. Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients.
Liegeois-Chauvel C; Marquis P; Gisselbrecht D; Pantieri R; Beaumont D; Chauvel P
Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):69S-72S. PubMed ID: 2757912
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic effects of gamma-vinyl GABA and carbamazepine.
Mervaala E; Partanen J; Nousianinen U; Sivenius J; Riekkinen P
Epilepsia; 1989; 30(2):189-93. PubMed ID: 2924744
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
